520 related articles for article (PubMed ID: 34663413)
1. Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy.
Bono S; Feligioni M; Corbo M
Mol Neurodegener; 2021 Oct; 16(1):71. PubMed ID: 34663413
[TBL] [Abstract][Full Text] [Related]
2. Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis.
Sarlette A; Krampfl K; Grothe C; Neuhoff Nv; Dengler R; Petri S
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1055-62. PubMed ID: 18957896
[TBL] [Abstract][Full Text] [Related]
3. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
4. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
5. TRIM16 protects from OGD/R-induced oxidative stress in cultured hippocampal neurons by enhancing Nrf2/ARE antioxidant signaling via downregulation of Keap1.
Ren X; Yu J; Guo L; Ma H
Exp Cell Res; 2020 Jun; 391(1):111988. PubMed ID: 32251645
[TBL] [Abstract][Full Text] [Related]
6. Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders.
Minj E; Yadav RK; Mehan S
Curr Mol Med; 2021; 21(8):630-644. PubMed ID: 33430731
[TBL] [Abstract][Full Text] [Related]
7. Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review.
Singh E; Matada GSP; Abbas N; Dhiwar PS; Ghara A; Das A
Inflammopharmacology; 2021 Oct; 29(5):1347-1355. PubMed ID: 34373972
[TBL] [Abstract][Full Text] [Related]
8. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
J Virol; 2020 May; 94(10):. PubMed ID: 32161178
[TBL] [Abstract][Full Text] [Related]
9. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
Foster A; Scott D; Layfield R; Rea SL
Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
[TBL] [Abstract][Full Text] [Related]
10. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling.
Goode A; Rea S; Sultana M; Shaw B; Searle MS; Layfield R
Mol Cell Neurosci; 2016 Oct; 76():52-58. PubMed ID: 27554286
[TBL] [Abstract][Full Text] [Related]
11. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease.
Geertsema S; Bourgonje AR; Fagundes RR; Gacesa R; Weersma RK; van Goor H; Mann GE; Dijkstra G; Faber KN
Trends Mol Med; 2023 Oct; 29(10):830-842. PubMed ID: 37558549
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
13. Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation.
Diaz-Amarilla P; Miquel E; Trostchansky A; Trias E; Ferreira AM; Freeman BA; Cassina P; Barbeito L; Vargas MR; Rubbo H
Free Radic Biol Med; 2016 Jun; 95():112-20. PubMed ID: 27012417
[TBL] [Abstract][Full Text] [Related]
14. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice.
Mimoto T; Miyazaki K; Morimoto N; Kurata T; Satoh K; Ikeda Y; Abe K
Brain Res; 2012 Mar; 1446():109-18. PubMed ID: 22353756
[TBL] [Abstract][Full Text] [Related]
15. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling.
Kaur G; Sharma A; Bhatnagar A
Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206
[TBL] [Abstract][Full Text] [Related]
16. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
[TBL] [Abstract][Full Text] [Related]
17. Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction.
Mundal SB; Rakner JJ; Silva GB; Gierman LM; Austdal M; Basnet P; Elschot M; Bakke SS; Ostrop J; Thomsen LCV; Moses EK; Acharya G; Bjørge L; Iversen AC
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216082
[TBL] [Abstract][Full Text] [Related]
18. Nrf2/Keap1/ARE signaling: Towards specific regulation.
Ulasov AV; Rosenkranz AA; Georgiev GP; Sobolev AS
Life Sci; 2022 Feb; 291():120111. PubMed ID: 34732330
[TBL] [Abstract][Full Text] [Related]
19. S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis.
Mead RJ; Higginbottom A; Allen SP; Kirby J; Bennett E; Barber SC; Heath PR; Coluccia A; Patel N; Gardner I; Brancale A; Grierson AJ; Shaw PJ
Free Radic Biol Med; 2013 Aug; 61():438-52. PubMed ID: 23608463
[TBL] [Abstract][Full Text] [Related]
20. Advances in developing noncovalent small molecules targeting Keap1.
Barreca M; Qin Y; Cadot MEH; Barraja P; Bach A
Drug Discov Today; 2023 Dec; 28(12):103800. PubMed ID: 37852355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
